Jaguar health reports voting results from special meeting of stockholders & announces december 23rd investor webinar

All proposals approved company not implementing a reverse split at this time swiss growth forum hosting investor webinar wednesday, december 23rd at 10:30 am eastern regarding appearance of new coronavirus strain underscoring urgency to seek european conditional approval for crofelemer for ‘long-hauler' syndrome gastrointestinal distress as strategy pursued in potential merger of napo eu with the european post pandemic recovery equity special purpose acquisition company (spac) san francisco, ca / accesswire / december 22, 2020 / jaguar health, inc. (nasdaq:jagx) (''jaguar'' or the ''company'') today announced the voting results of jaguar's december 9, 2020 special meeting of stockholders (the "special meeting"), which, as previously announced, was adjourned until december 22, 2020. two proposals were submitted to and approved by the stockholders of the company at the special meeting.
JAGX Ratings Summary
JAGX Quant Ranking